Tony Bhatt

Tony Bhatt specializes in pulmonary large cell neuroendocrine carcinoma (LCNEC), a rare and aggressive lung tumor with overlapping features with SCLC. His research has contributed to molecular classification of LCNEC distinguishing SCLC-like from NSCLC-like molecular subtypes with different chemotherapy sensitivities. He participates in international registry studies and rare tumor clinical trials for LCNEC and atypical carcinoids. His work helps clinicians navigate treatment decisions for these uncommon neuroendocrine lung tumors in the absence of dedicated phase III trial data.